Short-Term Non-Infectious Outcomes After a Pars Plana Intravitreal Antibiotic-Steroid Injection of Triamcinolone, Moxifloxacin, and Vancomycin During Cataract Surgery versus a Standard Postoperative Topical Regimen.
Zeeshan HaqMichael H ZhangMark J BenjaminKamran M RiazPublished in: Clinical ophthalmology (Auckland, N.Z.) (2020)
An intraoperative IVAS injection after uncomplicated cataract surgery may be as safe and effective as a standard topical regimen in terms of postoperative IOP and anterior chamber inflammatory events, respectively. However, the efficacy of a TMV formulation for CME prophylaxis appears to be unsatisfactory. Future studies with prospective and randomized designs are needed to further evaluate this technique.
Keyphrases
- cataract surgery
- patients undergoing
- ultrasound guided
- wound healing
- double blind
- open label
- drug delivery
- vascular endothelial growth factor
- oxidative stress
- placebo controlled
- diabetic retinopathy
- phase iii
- methicillin resistant staphylococcus aureus
- clinical trial
- urinary tract infection
- endothelial cells
- study protocol